Dali Li

11.2k total citations · 3 hit papers
164 papers, 6.0k citations indexed

About

Dali Li is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Dali Li has authored 164 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 29 papers in Genetics and 22 papers in Cancer Research. Recurrent topics in Dali Li's work include CRISPR and Genetic Engineering (40 papers), Pluripotent Stem Cells Research (12 papers) and Epigenetics and DNA Methylation (10 papers). Dali Li is often cited by papers focused on CRISPR and Genetic Engineering (40 papers), Pluripotent Stem Cells Research (12 papers) and Epigenetics and DNA Methylation (10 papers). Dali Li collaborates with scholars based in China, United States and Hong Kong. Dali Li's co-authors include Mingyao Liu, Jian Luo, Yiyun Cheng, Song Zhang, Jiangtao Shen, Liren Wang, Yanjiao Shao, Zhengfang Yi, Sung‐Gook Cho and Shenglan Li and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Dali Li

159 papers receiving 5.9k citations

Hit Papers

Strategies in the deliver... 2020 2026 2022 2024 2020 2022 2022 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dali Li 4.2k 1.2k 887 779 586 164 6.0k
Hideki Chiba 3.9k 0.9× 1.0k 0.9× 864 1.0× 1.0k 1.3× 524 0.9× 149 7.6k
Otmar Huber 5.4k 1.3× 891 0.8× 566 0.6× 520 0.7× 482 0.8× 109 8.0k
Stan Krajewski 3.7k 0.9× 857 0.7× 547 0.6× 635 0.8× 683 1.2× 74 5.7k
Futoshi Okada 2.9k 0.7× 1.2k 1.0× 340 0.4× 1.3k 1.7× 722 1.2× 174 5.9k
Wei Zhou 2.8k 0.7× 950 0.8× 557 0.6× 931 1.2× 304 0.5× 170 5.6k
Nuo Yang 3.6k 0.9× 687 0.6× 333 0.4× 1.5k 2.0× 667 1.1× 89 5.4k
Jeong‐Sun Seo 2.5k 0.6× 807 0.7× 675 0.8× 807 1.0× 329 0.6× 106 4.5k
Johan Kreuger 4.1k 1.0× 931 0.8× 466 0.5× 920 1.2× 593 1.0× 57 6.3k
Timothy F. Lane 4.6k 1.1× 2.0k 1.7× 1.7k 1.9× 1.4k 1.7× 1.1k 1.9× 69 8.9k

Countries citing papers authored by Dali Li

Since Specialization
Citations

This map shows the geographic impact of Dali Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dali Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dali Li more than expected).

Fields of papers citing papers by Dali Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dali Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dali Li. The network helps show where Dali Li may publish in the future.

Co-authorship network of co-authors of Dali Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dali Li. A scholar is included among the top collaborators of Dali Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dali Li. Dali Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Rui, Yu Liu, Yuwei Wang, et al.. (2025). PPDPF preserves integrity of proximal tubule by modulating NMNAT activity in chronic kidney diseases. Science Advances. 11(12). eadr8648–eadr8648. 1 indexed citations
2.
Wang, Yijie, Ying Chen, Yueming Xu, et al.. (2025). Cryo-EM structure of an activated GPR4–Gs signaling complex. Nature Communications. 16(1). 605–605. 1 indexed citations
3.
Yang, Ping, Zilong Geng, Yige Li, et al.. (2024). Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy. Circulation. 150(4). 283–298. 13 indexed citations
4.
Qin, Juliang, Ying Qian, Chenshen Huang, et al.. (2024). FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion. Journal of Hematology & Oncology. 17(1). 9–9. 24 indexed citations
5.
Liu, Xianyang, Xingyun Liao, Liu Y, et al.. (2023). A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing. Cellular and Molecular Immunology. 20(11). 1379–1392. 13 indexed citations
6.
Wang, Liren, Stefan Siwko, & Dali Li. (2023). Waking up the silenced beauty: CRISPR/Cas9 mediated reactivation of fetal hemoglobin genes to treat severe beta-thalassemia in young patients. PubMed. 2(2). lnad009–lnad009. 2 indexed citations
7.
Li, Yu, Yankang Zhang, Dongmei Wang, et al.. (2023). Rna M6a Methylation Regulates Glycolysis of Beige Fat and Contributes to Systemic Metabolic Homeostasis. Advanced Science. 10(25). e2300436–e2300436. 15 indexed citations
8.
Marín‐Müller, Christian, Dali Li, Jianming Lü, et al.. (2023). Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy. Pharmaceutics. 15(8). 2038–2038. 6 indexed citations
9.
Liu, Yanan, Kun Yuan, Guangliang Hong, et al.. (2023). Loss of PHF8 induces a viral mimicry response by activating endogenous retrotransposons. Nature Communications. 14(1). 4225–4225. 16 indexed citations
10.
Fu, Bin, Jiaoyang Liao, Shuanghong Chen, et al.. (2022). CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia. Nature Medicine. 28(8). 1573–1580. 109 indexed citations breakdown →
11.
Xu, Zhijiao, Jialin Chen, Meizhen Liu, et al.. (2022). Rescue of mis-splicing of a common SLC26A4 mutant associated with sensorineural hearing loss by antisense oligonucleotides. Molecular Therapy — Nucleic Acids. 28. 280–292. 13 indexed citations
12.
Li, Yu, Dongmei Wang, Yankang Zhang, et al.. (2022). Local hyperthermia therapy induces browning of white fat and treats obesity. Cell. 185(6). 949–966.e19. 141 indexed citations breakdown →
13.
Wu, Jiaxin, Yating Zhou, Wenqi Chen, et al.. (2022). Atf7ip and Setdb1 interaction orchestrates the hematopoietic stem and progenitor cell state with diverse lineage differentiation. Proceedings of the National Academy of Sciences. 120(1). e2209062120–e2209062120. 12 indexed citations
14.
Zhao, Xingsen, Yanjiao Shao, Xiaoya Duan, et al.. (2021). Mutation-induced DNMT1 cleavage drives neurodegenerative disease. Science Advances. 7(36). eabe8511–eabe8511. 15 indexed citations
15.
Zheng, Rui, Xiaoliang Fang, Xi Chen, et al.. (2020). Knockdown of lactate dehydrogenase by adeno‐associated virus‐delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1. SHILAP Revista de lepidopterología. 10(8). e261–e261. 26 indexed citations
16.
Yu, Guohua, Dali Li, Meng Wang, et al.. (2020). Photosensitive tyrosine analogues unravel site-dependent phosphorylation in TrkA initiated MAPK/ERK signaling. Communications Biology. 3(1). 706–706. 15 indexed citations
17.
Zhou, Lei, Ling Wang, Shiqiang Li, et al.. (2020). Bcl6 modulates innate immunity by controlling macrophage activity and plays critical role in experimental autoimmune encephalomyelitis. European Journal of Immunology. 50(4). 525–536. 24 indexed citations
18.
Yan, Xiaohe, et al.. (2018). Generation of a Novel Peroxidasin Knockout Mouse. Investigative Ophthalmology & Visual Science. 59(9). 325–325. 1 indexed citations
19.
Zhang, Yinli, Long‐Wen Zhao, Jue Zhang, et al.. (2018). DCAF 13 promotes pluripotency by negatively regulating SUV 39H1 stability during early embryonic development. The EMBO Journal. 37(18). 51 indexed citations
20.
Marín‐Müller, Christian, Dali Li, Uddalak Bharadwaj, et al.. (2013). A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer. Clinical Cancer Research. 19(21). 5901–5913. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026